The phrase "as potent as in" is correct and usable in written English.
It can be used to compare the effectiveness or strength of something in different contexts or situations.
Example: "The new formula is as potent as in previous versions, ensuring the same level of effectiveness."
Alternatives: "as effective as in" or "as strong as in".
For example, in the setting of an intact p53 checkpoint, replicative senescence initiated by critically shortened telomeres has been shown to be as potent as apoptosis in suppressing tumorigenesis in vivo [ 30, 31].
Because cytisine – a partial agonist of β2-containing receptors and a full agonist of β4-containing receptors (Papke and Heinemann, 1994) – was as potent as nicotine in inducing [3H]-ACh release in the rat IPN, we conclude that – as in mice – β4-containing receptors mediate this release.
8beta-VE2 is as potent as estradiol in binding and activating ERbeta in prostate preparations [ 36, 37] and in inducing apoptosis in human prostatic basal cells [ 28].
In vitro translation reactions in extracts programmed with the bicistronic mRNA, FF/HCV/Ren (Fig. S1A), revealed that although compound #7 inhibited FF translation to the greatest extent when compared to compounds 1 11 (Fig. 1B and Fig. S1B), it was not as potent as silvestrol in vitro (Figs. 1C) or in vivo (Fig. 1D).
EP was 4.6 times more potent than DES in activating hER-αand just as potent as DES in activating hER-β.
In regard to potency, it is not known whether a compound that is, for example, half as potent as BPA in vitro would have half the effect in vivo, especially because very little is known about the exposure and metabolism of BPS and BPF.
Despite its greater efficacy in vitro (Table 1), STX641 was not as potent as STX140 in vivo.
D9 is twice as potent as GD12 in a postexposure therapeutic setting and much more potent in a preexposure prophylactic setting.
In [ 60], DHT was 2.4 times as potent as T in maintaining prostate weight and duct lumen mass, and these quantities varied linearly with the concentration of either androgen.
In fact, we found that CagAEPISA was equally as potent as CagA in inducing the MLC-GFP central ring pattern.
